Nuclear Medicine and Biology
Volume 37, Issue 5 , Pages 539-546, July 2010

Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine

  • Sara Ahlgren

      Affiliations

    • Division of Nuclear Medicine, Department of Medical Sciences, Uppsala University, SE-751 85, Uppsala, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 18 471 3868; fax: +46 18 471 3432.
    • ,
  • Kristofer Andersson

      Affiliations

    • Division of Biomedical Radiation Sciences, Department of Oncology, Radiology and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
    • ,
  • Vladimir Tolmachev

      Affiliations

    • Division of Nuclear Medicine, Department of Medical Sciences, Uppsala University, SE-751 85, Uppsala, Sweden
    • Division of Biomedical Radiation Sciences, Department of Oncology, Radiology and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden

Received 10 December 2009; received in revised form 7 February 2010; accepted 23 February 2010. published online 09 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(10)00034-X

doi:10.1016/j.nucmedbio.2010.02.009

Nuclear Medicine and Biology
Volume 37, Issue 5 , Pages 539-546, July 2010

Article Tools

* Image Usage & Resolution